Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.39 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6302511 | 0.98 | HRH3 (0.41) | EHMT2EHMT1HRH3HRH4ALDH1A1 | |
| SCHEMBL6305135 | 0.97 | ALDH1A1 (0.38) | EHMT2EHMT1HRH3HRH4ALDH1A1 | |
| SCHEMBL6302885 | 0.89 | ALDH1A1 (0.40) | EHMT2EHMT1HRH3ALDH1A1MEN1 | |
| SCHEMBL6533138 | 0.88 | ALOX15 (0.41) | HRH3ALDH1A1MEN1KMT2ASIGMAR1 | |
| SCHEMBL6304851 | 0.86 | ALDH1A1 (0.40) | EHMT2EHMT1HRH3ALDH1A1MEN1 | |
| SCHEMBL6302848 | 0.85 | KDM1A (0.44) | HRH3ALDH1A1KMT2ASIGMAR1 | |
| SCHEMBL30786259 | 0.79 | L3MBTL1 (0.41) | HRH3HRH4ALDH1A1SIGMAR1L3MBTL1 | |
| SCHEMBL6308791 | 0.76 | PARP1 (0.41) | HRH3HRH4ALDH1A1L3MBTL1 | |
| SCHEMBL18235472 | 0.76 | LMNA (0.42) | ALDH1A1MEN1KMT2ASIGMAR1L3MBTL1 | |
| SCHEMBL522026 | 0.76 | NR5A2 (0.45) | ALDH1A1MEN1KMT2ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6949562-B2 | Heterocyclic compounds as ligands of the GABAA receptor | NEUROGEN CORPORATION (US) | 2005-09-27 | — | — | US | disclosed |
| US-6653471-B2 | Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction | NEUROGEN CORPORATION | 2003-11-25 | — | — | US | disclosed |